Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

This content is for healthcare professionals only.

Please confirm you are a healthcare professional.

Yes
No
iwNHL 2020 Session III

Novel Therapies Part I

Presentations
Novel ADCs
Laurie Sehn
11 September, 2020
CD20 / CD3 bispecific antibodies: How to choose?
Martin Hutchings, MD, PhD, The Finsen Center, National Hospital Copenhagen University Hospital, Copenhagen
11 September, 2020
Oral PI3K delta (δ) inhibitors in lymphoma
Jennifer Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA
11 September, 2020
Previous session View all sessions Next session

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals